Balance Sheet Components (Tables)

9 Months Ended

Sep. 30, 2022

Balance Sheet Components

Schedule of inventory

	September 30,		December 31,
	2022		2021
(in thousands)	(unaudited)
Raw Material	$	2,014	$	1,248
Work in Process		3,058		2,760
Finished Goods		1,529		892
Inventory	$	6,601	$	4,900

Schedule of property and equipment

	September 30,		December 31,
	2022		2021
(in thousands)	(unaudited)
Land	$	396	$	396
Lab equipment		477		403
Clinical equipment		65		65
Software		63		63
Furniture and fixtures		18		14
Computers and peripherals		7		7
Total property and equipment at cost		1,026		948
Accumulated depreciation		(454)		(298)
Property and equipment, net	$	572	$	650

Schedule of intangible assets

	September 30,		December 31,
	2022		2021
(in thousands)	(unaudited)
Developed technology	$	25,000	$	25,000
Accumulated developed technology amortization		(8,611)		(7,361)
Developed technology, net		16,389		17,639
In-process research and development		4,800		4,800
In process research and development, net		4,800		4,800
Trademarks		300		300
Accumulated trademark amortization		(103)		(88)
Trademarks, net		197		212
Internal use software costs - registry		1,236		—
Accumulated internal use software costs amortization		(61)		—
Internal use software costs - registry, net		1,175		—
Total intangible assets, net	$	22,561	$	22,651

Schedule of estimated future amortization expense of intangible assets with finite lives

The following table summarized the Company’s estimated future amortization expense of intangible assets with finite lives as of September 30, 2022:

(in thousands)	Amounts
Remainder of 2022	$	484
2023		1,934
2024		1,934
2025		1,934
2026		1,934
Thereafter		9,541
	$	17,761